Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
BRKR · against 1,336 other Healthcare companies
Ranked #837 of 1,337 · scores higher than 37% of peers
Bars: peers in each 10-point band of the valuation score133 peers with a valuation score of 30–39, including BRKR · Click a bar to see the companies
Mainly because of its earnings yield, which is weaker than most Healthcare peers.
| Metric | BRKR | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | -1.2% | 1.5% | 36% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | 5.2% | 4.2% | 56% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | 0.7% | -1.0% | 56% | 20% | |
| Book yieldHigher is better · 1,306 reported | 27.7% | 37.9% | 38% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 837 | 5.9B CNY (≈$824M) | 37 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 26 |
| 837 | 1.9B CNY (≈$270M) | 37 | 44 |
| 837 | 1.2B SGD (≈$945M) | 37 | 35 |
| 837 | 5.2B USD | 37 | 74 |
| 837 | 8.6B USD | 37 | 30 |
| 837 | 31.3B TRY (≈$938M) | 37 | 50 |
| 837 | 1.2B USD | 37 | 49 |
| 837 | 10.1B USD | 37 | 61 |
| 837 | 2.7B USD | 37 | 44 |